Trademark Overview
On Friday, October 10, 2025, a trademark application was filed for DHANYRA with the United States Patent and Trademark Office. The USPTO has given the DHANYRA trademark a serial number of 99436317. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, October 10, 2025. This trademark is owned by Kiniksa Pharmaceuticals, GmbH. The DHANYRA trademark is filed in the Pharmaceutical Products category with the following description:
Anti-inflammatories; Cardiovascular pharmaceuticals; Pharmaceutical preparations for the treatment and prevention of inflammatory diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases and disorders; Pharmaceutical preparations for the treatment and prevention of cardiac diseases and disorders; Pharmaceutical preparations for the treatment and prevention of immune-mediated diseases and disorders; Pharmaceutical preparations for the treatment and prevention of rare diseases and disorders